Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Diabetes, Obesity & Metabolism
|
October 5, 2023
Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists
Charlotte E Hinds, Ellie Peace, Shiqian Chen, et al.
Biochemical Pharmacology
|
June 15, 2021
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Phil Pickford, et al.
ACS Pharmacology & Translational Science
|
April 17, 2020
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists
Zijian Fang, Shiqian Chen, Philip Pickford, et al.
Molecular Metabolism
|
December 14, 2025
Spatially diffuse cAMP signalling with oppositely biased GLP-1 receptor agonists in β-cells despite differences in receptor localisation
Shiqian Chen, Carolina B Lobato, Carissa Wong, et al.
International Journal of Molecular Sciences
|
November 13, 2020
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang, Shiqian Chen, Yusman Manchanda, et al.
Diabetologia
|
June 25, 2026
Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion
Chiara Saponaro, Monica Imbernon, Isaline Louvet, et al.
Nature Genetics
|
September 7, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Diabetes, Obesity & Metabolism
|
October 5, 2023
Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists
Charlotte E Hinds, Ellie Peace, Shiqian Chen, et al.
Biochemical Pharmacology
|
June 15, 2021
Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1
Amaara Marzook, Shiqian Chen, Phil Pickford, et al.
ACS Pharmacology & Translational Science
|
April 17, 2020
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists
Zijian Fang, Shiqian Chen, Philip Pickford, et al.
Molecular Metabolism
|
December 14, 2025
Spatially diffuse cAMP signalling with oppositely biased GLP-1 receptor agonists in β-cells despite differences in receptor localisation
Shiqian Chen, Carolina B Lobato, Carissa Wong, et al.
International Journal of Molecular Sciences
|
November 13, 2020
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang, Shiqian Chen, Yusman Manchanda, et al.
Diabetologia
|
June 25, 2026
Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion
Chiara Saponaro, Monica Imbernon, Isaline Louvet, et al.
Nature Genetics
|
September 7, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
Page
of 3